Windlas Biotech Limited IPO

Windlas Biotech Limited is listed in the MAINBOARD segment with a price band of ₹448 to ₹460. The figures below are as reported by the exchanges and public sources.

Windlas Biotech Limited IPO — key facts

• The Windlas Biotech Limited IPO price band is ₹448 to ₹460 per share.
• As of 5 September 2026, the Windlas Biotech Limited IPO subscription status is 22.44x overall.
• The issue is open from 04-AUG-2021 to 06-AUG-2021.
• Windlas Biotech Limited listed on 16-AUG-2021.
• Windlas Biotech Limited listed at ₹406.7. The listing loss was 11.6% against the upper end of the issue price band.

Windlas Biotech Limited IPO details

Status

Listed

Segment

MAINBOARD

Sector

Pharmaceuticals

Price band

₹448 – ₹460

Issue size

₹401.54 Cr

Fresh issue

₹165 Cr

Offer for sale

₹236.54 Cr

Opens

04-AUG-2021

Closes

06-AUG-2021

Listing

16-AUG-2021

Total subscription

22.44x

Retail

24.22x

QIB

24.40x

NII

15.73x

Lead managers

Dam Capital (left lead)

Listing price

₹406.7

Listing day change

-11.6%

Other Pharmaceuticals IPOs

• Symbiotec Pharmalab Limited +10.9% on listing
• ABH Healthcare Limited -7.8% on listing
• Bio Medica Laboratories Limited -16.7% on listing
• Goldline Pharmaceutical Ltd. +32.0% on listing
• Sai Parenteral's Limited +3.7% on listing
• Speciality Medicines Ltd. +1.5% on listing

Live subscription, allotment status, offer documents and the full lifecycle timeline for this issue are on this page. Historical listing performance for every past IPO is in the IPO database, and each day's activity is recorded in the daily digest.

Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Data is reported for information only. It is not research and not investment advice. Investments in securities markets are subject to market risk; read all offer documents carefully before investing.